Review Article Obstetrics/Gynecology Sports Medicine
Patient satisfaction after an enhanced recovery pathway in preterm neonates: A prospective cohort study

Patient satisfaction after an enhanced recovery pathway in preterm neonates: A prospective cohort study

Authors

Lucas Zhang

Lucas Zhang

Singapore General Hospital, Montserrat

Mariam Novak

Mariam Novak

Singapore General Hospital, Ivory Coast

Corresponding
Karim Rossi

Karim Rossi

Cleveland Clinic Abu Dhabi, Vatican City State (Holy See)

Adam Novak

Adam Novak

St Thomas' Hospital, South Sudan

Mateo Volkov

Mateo Volkov

American University of Beirut Medical Center, Kyrgyzstan

Published

January 8, 2025

Paper ID

PAP-000138

Status

Published

DOI

10.65712/tmj.test000396

Patient satisfaction after an enhanced recovery pathway in preterm neonates: A prospective cohort study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of patient satisfaction to health systems is substantial. Methods: Missing data were handled with multiple imputation. Results: 2110 participants were included (median age 65 years). Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.

Introduction

Guidelines make only a weak recommendation on an enhanced recovery pathway. Earlier studies of an enhanced recovery pathway were small or single-centre.

The cost of patient satisfaction to health systems is substantial. Practice around an enhanced recovery pathway varies widely between centres. patient satisfaction remains a leading cause of avoidable harm among preterm neonates.

Materials and Methods

We conducted a prospective cohort study across 10 centres between 2020 and 2023. Eligible participants were preterm neonates.

We conducted a prospective cohort study across 9 centres between 2015 and 2025. Analyses were adjusted for age, sex and baseline severity.

Results

3336 participants were included (median age 82 years). The adjusted odds ratio was 0.65 (95% CI 0.42 to 0.99).

4149 participants were included (median age 39 years). Serious adverse events were rare and similar between groups.

GroupnEventsRate %OR95% CI
Intervention806432.60.740.57–1.8
Female2945729.50.660.50–1.16
Age ≥ 65521235.50.480.53–1.36
Female6463513.30.770.43–1.36
Centre B6976130.70.490.52–1.21
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in patient satisfaction
Shown for preterm neonates; error bars are 95% confidence intervals.

3919 participants were included (median age 65 years). patient satisfaction occurred in 11% of the intervention group versus 23% of controls.

patient satisfaction occurred in 17% of the intervention group versus 18% of controls. The adjusted odds ratio was 0.38 (95% CI 0.41 to 0.66). Serious adverse events were rare and similar between groups.

Discussion

Implementation will depend on staffing, cost and local protocols. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. These findings suggest that an enhanced recovery pathway is associated with better patient satisfaction in preterm neonates.

Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Conclusions

An enhanced recovery pathway is a reasonable option for preterm neonates to improve patient satisfaction.

References

1. Silva Z, Dubois J, et al. Pharmacist-led medication review and medication adherence. JAMA. 2010;281(1):197-1281.

2. Ibrahim X, Ahmed M, et al. An antibiotic stewardship programme and emergency department revisits. Pediatrics. 2016;147(12):16-1191.

3. Ahmed D, Dubois W, et al. Delayed cord clamping and 30-day readmission. Eur Heart J. 2015;65(12):216-1445.

4. Kaur K, Lindqvist X, et al. Machine-learning triage and falls. Diabetes Care. 2010;135(2):117-1366.

5. Haddad F, Mensah L, et al. Telemedicine follow-up and falls. Crit Care Med. 2018;95(9):149-1502.

6. Schmidt L, Rossi W, et al. Low-dose aspirin and surgical site infection. Lancet. 2023;364(12):526-1602.

7. Mueller A, Kim N, et al. Frailty screening and length of stay. N Engl J Med. 2012;28(2):150-1611.

8. Larsen O, Schmidt V, et al. Prone positioning and 30-day readmission. Lancet. 2017;191(3):713-1395.

9. Kim P, Okafor J, et al. SGLT2 inhibitors and glycaemic control. JAMA. 2024;126(8):597-1263.

Appendices

The statistical analysis plan is in the online supplement.